Related Experiment Videos
[Delta hepatitis as a mixed infection]
Vrachebnoe Delo
|March 1, 1990
Summary
Hepatitis B virus (HBV) coinfection and delta superinfection significantly worsen liver disease outcomes. Delta superinfection often leads to severe chronic hepatitis resistant to treatment.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis B virus (HBV) infection is a global health concern.
- The delta agent (HDV) is a unique RNA virus that requires HBV for replication.
- Understanding the impact of HBV and HDV co-infection and superinfection is crucial for patient management.
Observation:
- Radioimmunoassay detected anti-delta agents in 8 out of 247 patients.
- Three patients had HBV and HDV coinfection; five had HDV superinfection.
- One coinfected patient experienced fatal fulminant hepatitis with acute liver dystrophy.
Findings:
- Coinfection with HBV and HDV led to severe hepatitis in two patients who recovered.
- HDV superinfection accelerated disease progression, causing early chronic active hepatitis.
- This chronic form exhibited aggressive behavior and resistance to immunosuppressive therapy.
Implications:
- Coinfection and superinfection with the delta agent significantly alter HBV disease course.
- Delta superinfection poses a particular risk for developing severe, refractory chronic hepatitis.
- Clinical and biochemical monitoring is essential for differentiating and managing these complex viral hepatitis cases.